{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T03:33:00Z","timestamp":1783567980171,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2003,8,1]],"date-time":"2003-08-01T00:00:00Z","timestamp":1059696000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2003,8]]},"DOI":"10.1007\/bf03347351","type":"journal-article","created":{"date-parts":[[2014,3,31]],"date-time":"2014-03-31T08:44:00Z","timestamp":1396255440000},"page":"710-717","source":"Crossref","is-referenced-by-count":24,"title":["Is there a therapeutic role for octreotide in patients with ectopic Cushing\u2019s syndrome?"],"prefix":"10.1007","volume":"26","author":[{"given":"G. I.","family":"Uwaifo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. A.","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Hirshberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. C.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Hartzband","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. K.","family":"Nieman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Pacak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,31]]},"reference":[{"key":"BF03347351_CR1","first-page":"42","volume":"85","author":"NJ Sarlis","year":"2000","unstructured":"Sarlis NJ, Chanock SJ, Nieman LK. Cortisolemic indices predict severe infections in Cushing syndrome due to ectopic production of adrenocorticotropin. J Clin Endocrinol Metab 2000, 85: 42\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03347351_CR2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/BF01655518","volume":"10","author":"RG Watson","year":"1986","unstructured":"Watson RG, van Heerden JA, Northcutt RC, Grant CS, Ilstrup DM. Results of adrenal surgery for Cushing\u2019s syndrome: 10 years\u2019 experience. World J Surg 1986, 10: 531\u20138.","journal-title":"World J Surg"},{"key":"BF03347351_CR3","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1056\/NEJM199910283411814","volume":"341","author":"CA Koch","year":"1999","unstructured":"Koch CA, Doppman JL, Watson JC, Patronas NJ, Nieman LK. Spinal epidural lipomatosis in a patient with the ectopic corticotropin syndrome. N Engl J Med 1999, 341: 1399\u2013400.","journal-title":"N Engl J Med"},{"key":"BF03347351_CR4","first-page":"4104","volume":"86","author":"J Krakoff","year":"2001","unstructured":"Krakoff J, Koch CA, Calis KA, Alexander RH, Nieman LK. Use of a parenteral propylene glycol-containing etomidate preparation for the long-term management of ectopic Cushing\u2019s syndrome. J Clin Endocrinol Metab 2001, 86: 4104\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03347351_CR5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0026-0495(96)90107-9","volume":"45","author":"K Werder von","year":"1996","unstructured":"von Werder K, Muller OA, Stalla GK. Somatostatin analogs in ectopic corticotropin production. Metabolism 1996, 45: 129\u201331.","journal-title":"Metabolism"},{"key":"BF03347351_CR6","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/pgmj.74.868.108","volume":"74","author":"J Matte","year":"1998","unstructured":"Matte J, Roufosse F, Rocmans P, Schoutens A, Jacobovitz D, Mockel J. Ectopic Cushing\u2019s syndrome and pulmonarycarcinoid tumour identified by [111In-DTPA-D-Phe1] octreotide. Postgrad Med J 1998, 74: 108\u201310.","journal-title":"Postgrad Med J"},{"key":"BF03347351_CR7","first-page":"515","volume":"162","author":"A Kristoffersson","year":"1996","unstructured":"Kristoffersson A, Olsson T, Bjornebrink J, Hagg E. Diagnosis of ectopic ACTH production from a bronchial carcinoid by imaging with octreotide scintigraphy. Eur J Surg 1996, 162: 515\u20138.","journal-title":"Eur J Surg"},{"key":"BF03347351_CR8","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1378\/chest.109.3.845","volume":"109","author":"S Christin-Maitre","year":"1996","unstructured":"Christin-Maitre S, Chabbert-Buffet N, Mure A, Boukhris R, Bouchard P. Use of somatostatin analog for localization and treatment of ACTH secreting bronchial carcinoid tumor. Chest 1996, 109: 845\u20136.","journal-title":"Chest"},{"key":"BF03347351_CR9","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1365-2265.1995.tb00548.x","volume":"43","author":"S Tsagarakis","year":"1995","unstructured":"Tsagarakis S, Giannakenas C, Vassilakos PJ, et al. Successful localization of an occult ACTH-secreting bronchial carcinoid tumour with 111indium-DTPA labelled octreotide. Clin Endocrinol (Oxf) 1995, 43: 763\u20137.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BF03347351_CR10","first-page":"20","volume":"78","author":"M Phlipponneau","year":"1994","unstructured":"Phlipponneau M, Nocaudie M, Epelbaum J, et al. Somatostatin analogs for the localization and preoperative treatment of an adrenocorticotropin-secreting bronchial carcinoid tumor. J Clin Endocrinol Metab 1994, 78: 20\u20134.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03347351_CR11","first-page":"511","volume":"36","author":"A Oliaro","year":"1995","unstructured":"Oliaro A, Filosso PL, Casadio C, et al. Bronchial carcinoid associated with Cushing\u2019s syndrome. J Cardiovasc Surg 1995, 36: 511\u20134.","journal-title":"J Cardiovasc Surg"},{"key":"BF03347351_CR12","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0002-9343(94)90059-0","volume":"96","author":"WW Herder de","year":"1994","unstructured":"de Herder WW, Krenning EP, Malchoff CD, et al. Somatostatin receptor scintigraphy: its value in tumor localization in patients with Cushing\u2019s syndrome caused by ectopic corticotropin or corticotropin-releasing hormone secretion. Am J Med 1994, 96: 305\u201312.","journal-title":"Am J Med"},{"key":"BF03347351_CR13","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1210\/jcem.84.4.5583","volume":"84","author":"A Tabarin","year":"1999","unstructured":"Tabarin A, Valli N, Chanson P, et al. Usefulness of somatostatin receptor scintigraphy in patients with occult ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab 1999, 84: 1193\u2013202.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03347351_CR14","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1210\/jcem.84.4.5576","volume":"84","author":"DJ Torpy","year":"1999","unstructured":"Torpy DJ, Chen CC, Mullen N, et al. Lack of utility of 111Inpentetreotide scintigraphy in localizing ectopic ACTH producing tumors: follow-up of 18 patients. J Clin Endocrinol Metab 1999, 84: 1186\u201392.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03347351_CR15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0026-0495(96)90091-8","volume":"45","author":"WW Herder de","year":"1996","unstructured":"de Herder WW, Lamberts SW. Is there a role for somatostatin and its analogs in Cushing\u2019s syndrome? Metabolism 1996, 45: 83\u20135.","journal-title":"Metabolism"},{"key":"BF03347351_CR16","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1507\/endocrj1954.37.923","volume":"37","author":"S Suzuki","year":"1990","unstructured":"Suzuki S, Hashizume K, Kobayashi M, et al. Somatostatin analogue (SMS 201\u2013995) decreases plasma levels of corticotropin (ACTH) and corticotropin-releasing hormone in a patient with ectopic ACTH-producing tumors. Endocrinol Jpn 1990, 37: 923\u201332.","journal-title":"Endocrinol Jpn"},{"key":"BF03347351_CR17","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1365-2265.1998.00510.x","volume":"49","author":"A Bruel Van den","year":"1998","unstructured":"Van den Bruel A, Bex M, Van Dorpe J, Heyns W, Bouillon R. Occult ectopic ACTH secretion due to recurrent lung carcinoid: long-term control of hypercortisolism by continuous subcutaneous infusion of octreotide. Clin Endocrinol (Oxf) 1998, 49: 541\u20136.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BF03347351_CR18","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1055\/s-0029-1211252","volume":"101","author":"G Rosa De","year":"1993","unstructured":"De Rosa G, Testa A, Liberale I, Pirronti T, Granone P, Picciocchi A. Successful treatment of ectopic Cushing\u2019s syndrome with the long-acting somatostatin analog octreotide. Exp Clin Endocrinol 1993, 101: 319\u201325.","journal-title":"Exp Clin Endocrinol"},{"key":"BF03347351_CR19","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1365-2265.1992.tb01461.x","volume":"36","author":"NW Cheung","year":"1992","unstructured":"Cheung NW, Boyages SC. Failure of somatostatin analogue to control Cushing\u2019s syndrome in 2 cases of ACTH-producing carcinoid tumours. Clin Endocrinol (Oxf) 1992, 36: 361\u20137.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BF03347351_CR20","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0002-9343(93)90283-U","volume":"95","author":"NJ Woodhouse","year":"1993","unstructured":"Woodhouse NJ, Dagogo-Jack S, Ahmed M, Judzewitsch R. Acute and long-term effects of octreotide in patients with ACTH-dependent Cushing\u2019s syndrome. Am J Med 1993, 95: 305\u20138.","journal-title":"Am J Med"},{"key":"BF03347351_CR21","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000182737","volume":"39","author":"M Rieu","year":"1993","unstructured":"Rieu M, Rosilio M, Richard A, Vannetzel JM, Kuhn JM. Paradoxical effect of somatostatin analogues on the ectopic secretion of corticotropin in 2 cases of small cell lung carcinoma. Horm Res 1993, 39: 207\u201312.","journal-title":"Horm Res"},{"key":"BF03347351_CR22","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/0140-6736(91)92293-B","volume":"338","author":"M Duquenne","year":"1991","unstructured":"Duquenne M, Dousset B, Weryha G, et al. Paradoxical effect of octreotide in neoplastic inappropriate corticotropin secretion. Lancet 1991, 338: 1407\u20138.","journal-title":"Lancet"},{"key":"BF03347351_CR23","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/pgmj.75.880.96","volume":"75","author":"NN Chan","year":"1999","unstructured":"Chan NN, Isaacs AJ. Lack of response to octreotide in Cushing\u2019s syndrome due to metastatic adrenocortical carcinoma. Postgrad Med J 1999, 75: 96\u20137.","journal-title":"Postgrad Med J"},{"key":"BF03347351_CR24","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00019616-199909000-00013","volume":"9","author":"J Diez","year":"1999","unstructured":"Diez J, Iglesias P. Successful treatment of ectopic Cushing\u2019s syndrome with the slow release somatostatin analog lanreotide: Case report. The Endocrinologist 1999, 9: 399\u2013402.","journal-title":"The Endocrinologist"},{"key":"BF03347351_CR25","first-page":"140","volume":"43","author":"A Parthiban","year":"1995","unstructured":"Parthiban A, Sundaram DS, Reddy DJ, Girinath MR, Prabhakaran R, Chidambaranathan N. Octreotide and ketoconazole for persistent ectopic ACTH Cushing\u2019s disease due to mediastinal carcinoid. J Assoc Physicians India 1995, 43: 140.","journal-title":"J Assoc Physicians India"},{"key":"BF03347351_CR26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF01665863","volume":"69","author":"E Kornely","year":"1991","unstructured":"Kornely E, Schlaghecke R, Horster FA. Palliative therapy of an ectopic Cushing\u2019s syndrome due to a metastatic carcinoid tumor. Klin Wochenschr 1991, 69: 173\u20136.","journal-title":"Klin Wochenschr"},{"key":"BF03347351_CR27","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/pgmj.75.880.98","volume":"75","author":"GV Gill","year":"1999","unstructured":"Gill GV, Yong A, Power E, Ramage J. Carcinoid-associated ectopic ACTH syndrome with variable response to octreotide. Postgrad Med J 1999, 75: 98\u2013100.","journal-title":"Postgrad Med J"},{"key":"BF03347351_CR28","first-page":"647","volume":"19","author":"J Newell-Price","year":"1998","unstructured":"Newell-Price J, Trainer P, Besser M, Grossman A. The diagnosis and differential diagnosis of Cushing\u2019s syndrome and pseudo-Cushing\u2019s states. Endocr Rev 1998, 19: 647\u201372.","journal-title":"Endocr Rev"},{"key":"BF03347351_CR29","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.1210\/jcem.84.11.6126","volume":"84","author":"CA Koch","year":"1999","unstructured":"Koch CA, Azumi N, Furlong MA, et al. Carcinoid syndrome caused by an atypical carcinoid of the uterine cervix. J Clin Endocrinol Metab 1999, 84: 4209\u201313.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03347351_CR30","first-page":"1184","volume":"84","author":"WW Herder de","year":"1999","unstructured":"de Herder WW, Lamberts SW. Tumor localization \u2014 the ectopic ACTH syndrome. J Clin Endocrinol Metab 1999, 84: 1184\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03347351_CR31","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0163-7258(93)90009-3","volume":"60","author":"G Weckbecker","year":"1993","unstructured":"Weckbecker G, Raulf F, Stolz B, Bruns C. Somatostatin analogs for diagnosis and treatment of cancer. Pharmacol Ther 1993, 60: 245\u201364.","journal-title":"Pharmacol Ther"},{"key":"BF03347351_CR32","first-page":"89","volume":"190","author":"C Bruns","year":"1995","unstructured":"Bruns C, Weckbecker G, Raulf F, Lubbert H, Hoyer D. Characterization of somatostatin receptor subtypes. Ciba Found Symp 1995, 190: 89\u2013101.","journal-title":"Ciba Found Symp"},{"key":"BF03347351_CR33","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0950-3528(96)90014-7","volume":"10","author":"WW Herder de","year":"1996","unstructured":"de Herder WW, Hofland LJ, van der Lely AJ, Lamberts SW. Peptide receptors in gut endocrine tumours. Baillieres Clin Gastroenterol 1996, 10: 571\u201387.","journal-title":"Baillieres Clin Gastroenterol"},{"key":"BF03347351_CR34","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0950-351X(96)80362-4","volume":"10","author":"LJ Hofland","year":"1996","unstructured":"Hofland LJ, Lamberts SW. Somatostatin receptors and disease: role of receptor subtypes. Baillieres Clin Endocrinol Metab 1996, 10: 163\u201376.","journal-title":"Baillieres Clin Endocrinol Metab"},{"key":"BF03347351_CR35","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0006-2952(95)00066-9","volume":"50","author":"LJ Hofland","year":"1995","unstructured":"Hofland LJ, Visser-Wisselaar HA, Lamberts SW. Somatostatin analogs: clinical application in relation to human somatostatin receptor subtypes. Biochem Pharmacol 1995, 50: 287\u201397.","journal-title":"Biochem Pharmacol"},{"issue":"Suppl1","key":"BF03347351_CR36","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1530\/eje.0.143S021","volume":"143","author":"EG Lichtenauer-Kaligis","year":"2000","unstructured":"Lichtenauer-Kaligis EG, van Hagen PM, Lamberts SW, Hofland LJ. Somatostatin receptor subtypes in human immune cells. Eur J Endocrinol 2000, 143 (Suppl 1): S21\u20135.","journal-title":"Eur J Endocrinol"},{"issue":"Suppl2","key":"BF03347351_CR37","first-page":"28","volume":"31","author":"D Ferone","year":"1999","unstructured":"Ferone D, van Hagen PM, Colao A, Annunziato L, Lamberts SW, Hofland LJ. Somatostatin receptors in the thymus. Ann Med 1999, 31 (Suppl 2): 28\u201333.","journal-title":"Ann Med"},{"key":"BF03347351_CR38","first-page":"471","volume":"70","author":"JC Reubi","year":"1997","unstructured":"Reubi JC, Schaer JC, Markwalder R, Waser B, Horisberger U, Laissue J. Distribution of somatostatin receptors in normal and neoplastic human tissues: recent advances and potential relevance. Yale J Biol Med 1997, 70: 471\u20139.","journal-title":"Yale J Biol Med"},{"key":"BF03347351_CR39","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1749-6632.1994.tb17262.x","volume":"733","author":"JC Reubi","year":"1994","unstructured":"Reubi JC, Laissue J, Waser B, Horisberger U, Schaer JC. Expression of somatostatin receptors in normal, inflamed, and neoplastic human gastrointestinal tissues. Ann N Y Acad Sci 1994, 733: 122\u201337.","journal-title":"Ann N Y Acad Sci"},{"key":"BF03347351_CR40","first-page":"2161","volume":"86","author":"MC Zatelli","year":"2001","unstructured":"Zatelli MC, Tagliati F, Taylor JE, Rossi R, Culler MD, degli Uberti EC. Somatostatin receptor subtypes 2 and 5 differentially affect proliferation in vitro of the human medullary thyroid carcinoma cell line tt. J Clin Endocrinol Metab 2001, 86: 2161\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03347351_CR41","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0026-0495(90)90217-Z","volume":"39","author":"JC Reubi","year":"1990","unstructured":"Reubi JC, Kvols L, Krenning E, Lamberts SW. Distribution of somatostatin receptors in normal and tumor tissue. Metabolism 1990, 39: 78\u201381.","journal-title":"Metabolism"},{"key":"BF03347351_CR42","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/pgmj.72.849.403","volume":"72","author":"WW Herder de","year":"1996","unstructured":"de Herder WW, van der Lely AJ, Lamberts SW. Somatostatin analogue treatment of neuroendocrine tumours. Postgrad Med J 1996, 72: 403\u20138.","journal-title":"Postgrad Med J"},{"key":"BF03347351_CR43","first-page":"222","volume":"190","author":"SW Lamberts","year":"1995","unstructured":"Lamberts SW, de Herder WW, van Koetsveld PM, et al. Somatostatin receptors: clinical implications for endocrinology and oncology. Ciba Found Symp 1995, 190: 222\u201336.","journal-title":"Ciba Found Symp"},{"key":"BF03347351_CR44","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1046\/j.1365-2265.1998.00456.x","volume":"49","author":"RA James","year":"1998","unstructured":"James RA. Octreotide and ectopic Cushing\u2019s syndrome \u2014 a commentary. Clin Endocrinol (Oxf) 1998, 49: 419\u201320.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BF03347351_CR45","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF03349555","volume":"13","author":"B Ambrosi","year":"1990","unstructured":"Ambrosi B, Bochicchio D, Fadin C, Colombo P, Faglia G. Failure of somatostatin and octreotide to acutely affect the hypothalamic-pituitary-adrenal function in patients with corticotropin hypersecretion. J Endocrinol Invest 1990, 13: 257\u201361.","journal-title":"J Endocrinol Invest"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03347351.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03347351\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03347351","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T06:43:32Z","timestamp":1558507412000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03347351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2003,8]]}},"alternative-id":["BF03347351"],"URL":"https:\/\/doi.org\/10.1007\/bf03347351","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,8]]}}}